BioElectronics Founder and CEO Andrew J. Whelan Has Died Suddenly
October 07, 2019 12:37 ET
|
BioElectronics Corporation
FREDERICK, MD, Oct. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corp. (OTCPK: BIEL) is sad to announce that its founder and CEO, Andrew J. Whelan, died suddenly last night at his...
Update: BioElectronics Announces Publication of a Study of the ActiPatch Medical Device as an Effective Long-Term Treatment for Chronic Pain
October 02, 2019 21:29 ET
|
BioElectronics Corporation
FREDERICK, MD, Oct. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL) www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to...
BioElectronics Announces Publication of a Study of the ActiPatch Medical Device as an Effective Long-Term Treatment for Chronic Pain
October 02, 2019 09:44 ET
|
BioElectronics Corporation
FREDERICK, MD, Oct. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL) www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to...
BioElectronics Files FDA 510(k) Application for Musculoskeletal Pain Complaints; Clinical Data Demonstrates Superior Drug Free Pain Relief to Prescription Strength NSAID Drug
August 20, 2019 08:30 ET
|
BioElectronics Corporation
FREDERICK, MD, Aug. 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, is pleased to announce that it has filed a 510(k), Premarket...
BioElectronics Announces FDA Market Clearance for Its Non-Opioid Postoperative Pain Therapy
July 01, 2019 08:57 ET
|
BioElectronics Corporation
FREDERICK, MD, July 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to...
BioElectronics Announces Publication of Study Verifying the Effectiveness of Its ActiPatch Medical Device on Chronic Pain
June 03, 2019 09:31 ET
|
BioElectronics Corporation
FREDERICK, MD, June 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL) www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to...
BioElectronics Announces Withdrawal and Planned Resubmission of 510(k) for General Musculoskeletal Pain
May 22, 2019 10:43 ET
|
BioElectronics Corporation
FREDERICK, MD, May 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL) www.bielcorp.com, the maker of non-invasive electroceutical devices, announced today...
BioElectronics Responds to FDA’s 510(k) Additional Information Requests for its Musculoskeletal Pain Relief and Postoperative Pain Applications
April 23, 2019 08:30 ET
|
BioElectronics Corporation
FREDERICK, MD, April 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com announced that the Company has submitted its response to the U.S....
BioElectronics Announces Back Pain Clinical Study with Leading Australian Pain Center
March 08, 2019 10:36 ET
|
BioElectronics Corporation
Pulsed Shortwave Neuromodulation Therapy (ActiPatch®) Study in Chronic Lower Back Pain FREDERICK, MD, March 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC...
BioElectronics Files FDA Applications for Treatment of Musculoskeletal & Postoperative Pain
February 12, 2019 08:00 ET
|
BioElectronics Corporation
FREDERICK, MD, Feb. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce that two Traditional 510(k) Premarket...